SA
IONS icon

Sicart Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.32M Sell
185,296
-350
-0.2% -$13.8K 2.56% 14
2025
Q1
$5.6M Sell
185,646
-175
-0.1% -$5.28K 1.94% 22
2024
Q4
$6.5M Sell
185,821
-5,702
-3% -$199K 2.32% 17
2024
Q3
$7.67M Hold
191,523
2.69% 14
2024
Q2
$9.13M Sell
191,523
-2,470
-1% -$118K 3.5% 7
2024
Q1
$8.41M Sell
193,993
-300
-0.2% -$13K 3.08% 11
2023
Q4
$9.83M Sell
194,293
-8,839
-4% -$447K 3.76% 6
2023
Q3
$9.21M Sell
203,132
-1,815
-0.9% -$82.3K 3.61% 9
2023
Q2
$8.41M Sell
204,947
-5,751
-3% -$236K 3.27% 10
2023
Q1
$7.53M Sell
210,698
-35,560
-14% -$1.27M 2.93% 11
2022
Q4
$9.3M Sell
246,258
-7,718
-3% -$292K 3.28% 9
2022
Q3
$11.2M Sell
253,976
-34,775
-12% -$1.54M 3.98% 5
2022
Q2
$10.7M Sell
288,751
-16,031
-5% -$593K 3.33% 8
2022
Q1
$11.3M Buy
304,782
+22,251
+8% +$824K 2.92% 9
2021
Q4
$8.63M Sell
282,531
-8,723
-3% -$266K 2.25% 16
2021
Q3
$9.77M Sell
291,254
-77,155
-21% -$2.59M 2.66% 14
2021
Q2
$14.7M Sell
368,409
-1,889
-0.5% -$75.4K 3.5% 8
2021
Q1
$16.6M Sell
370,298
-32,610
-8% -$1.47M 4.4% 5
2020
Q4
$22.8M Sell
402,908
-15,387
-4% -$870K 5.62% 2
2020
Q3
$19.8M Sell
418,295
-1,077
-0.3% -$51.1K 5.93% 3
2020
Q2
$24.7M Sell
419,372
-10,380
-2% -$612K 7.91% 2
2020
Q1
$20.3M Buy
429,752
+18,940
+5% +$895K 7.74% 2
2019
Q4
$24.8M Buy
410,812
+275
+0.1% +$16.6K 8.27% 1
2019
Q3
$24.6M Sell
410,537
-2,835
-0.7% -$170K 8.07% 1
2019
Q2
$26.6M Sell
413,372
-3,613
-0.9% -$232K 10.8% 1
2019
Q1
$33.8M Sell
416,985
-104,974
-20% -$8.52M 14.3% 1
2018
Q4
$28.2M Sell
521,959
-1,885
-0.4% -$102K 13.66% 1
2018
Q3
$27M Sell
523,844
-50
-0% -$2.58K 12.96% 1
2018
Q2
$21.8M Buy
523,894
+177,082
+51% +$7.38M 11.45% 1
2018
Q1
$15.3M Sell
346,812
-51,260
-13% -$2.26M 9.13% 2
2017
Q4
$20M Buy
398,072
+9,050
+2% +$455K 10.57% 1
2017
Q3
$19.7M Buy
389,022
+1,700
+0.4% +$86.2K 14.11% 1
2017
Q2
$19.7M Buy
387,322
+19,962
+5% +$1.02M 14.32% 1
2017
Q1
$14.8M Buy
367,360
+87,045
+31% +$3.5M 10.67% 1
2016
Q4
$13.4M Buy
+280,315
New +$13.4M 9.25% 1